BOTTOSSO, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 416
AS - Asia 239
EU - Europa 189
AF - Africa 11
SA - Sud America 10
OC - Oceania 1
Totale 866
Nazione #
US - Stati Uniti d'America 413
SG - Singapore 129
IT - Italia 92
CN - Cina 79
FI - Finlandia 22
HK - Hong Kong 22
DE - Germania 20
GB - Regno Unito 11
BR - Brasile 10
RU - Federazione Russa 9
CZ - Repubblica Ceca 8
FR - Francia 7
NL - Olanda 6
CI - Costa d'Avorio 5
EG - Egitto 5
SE - Svezia 4
AT - Austria 3
BE - Belgio 3
ES - Italia 2
IE - Irlanda 2
IL - Israele 2
IR - Iran 2
AU - Australia 1
AZ - Azerbaigian 1
CA - Canada 1
IN - India 1
JM - Giamaica 1
JO - Giordania 1
MX - Messico 1
MY - Malesia 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 866
Città #
Chandler 82
Singapore 80
Ashburn 23
Beijing 21
Boardman 19
Fairfield 19
Helsinki 19
Hong Kong 17
Santa Clara 17
Cambridge 16
Padova 15
Wilmington 11
San Diego 9
New York 8
London 7
Los Angeles 7
Medford 7
Olomouc 7
Princeton 7
Rome 7
Seattle 7
Abidjan 5
Houston 5
Menouf 5
Milan 5
Roxbury 5
Ann Arbor 4
Miami 4
Salt Lake City 4
Shanghai 4
Villafranca Padovana 4
Woodbridge 4
Brussels 3
Chicago 3
Codogno 3
Council Bluffs 3
Des Moines 3
Hamburg 3
Lappeenranta 3
Selvazzano Dentro 3
Sterling 3
Venice 3
Acerra 2
Barcelona 2
Bologna 2
Buffalo 2
Capo d'Orlando 2
Clermont-Ferrand 2
Dallas 2
Dublin 2
Falkenstein 2
Guangzhou 2
Legnaro 2
Modena 2
Naples 2
Nuremberg 2
Rehovot 2
Sale Marasino 2
Selargius 2
Sestu 2
Turin 2
Vimercate 2
Washington 2
Alvorada 1
Amman 1
Baku 1
Binzhou 1
Boa Vista 1
Cardiff 1
Casalnuovo di Napoli 1
East London 1
Florence 1
Frankfurt am Main 1
Garanhuns 1
Girau do Ponciano 1
Grimsby 1
Gunzenhausen 1
Gustavo Adolfo Madero 1
Hangzhou 1
Islington 1
Jinan 1
Kilburn 1
Kingston 1
Kuala Lumpur 1
Langfang 1
Marche 1
Melbourne 1
Newark 1
Norwalk 1
Ottawa 1
Parma 1
Phoenix 1
Pirapora 1
Pistoia 1
Prague 1
Pune 1
Rio de Janeiro 1
Rockville 1
Shenyang 1
Springfield 1
Totale 563
Nome #
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer 83
Evolution of HER2-low expression from primary to recurrent breast cancer 76
A comprehensive profiling of the immune microenvironment of breast cancer brain metastases 70
Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases 67
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy 60
A prognostic model based on residual cancer burden and tumor-infiltrating lymphocytes on residual disease after neoadjuvant therapy in HER2+ breast cancer 56
Gene-expression signatures to inform neoadjuvant treatment decision in HR+/HER2− breast cancer: Available evidence and clinical implications 54
Clinical applications of radiomics and deep learning in breast and lung cancer: A narrative literature review on current evidence and future perspectives 52
Gastric metastases of breast cancer: Histopathological and molecular characterization of a single Institution case series 48
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment 44
Cardiac Safety of Adjuvant Trastuzumab and Paclitaxel for HER2+ early breast cancer patients published in Abstract Book of the 21th National Congress of Italian Association of Medical Oncology (AIOM) 25-27 October, 2019 - Rome, Italy Abstracts 39
Oligometastatic breast cancer: Dissecting the clinical and biological uniqueness of this emerging entity. Can we pursue curability? 36
HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial 33
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2- BC patients with residual disease after neoadjuvant chemotherapy: a cohort study 33
Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival 30
Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: Real-world data from a multicentric European cohort 30
Gene-expression assays to tailor adjuvant endocrine therapy for HR+/HER2- breast cancer 28
Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patients 26
Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases 25
HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome 5
Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome 5
Totale 900
Categoria #
all - tutte 6.674
article - articoli 6.674
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.348


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202131 0 0 0 5 0 5 5 2 10 2 0 2
2021/202285 0 0 3 4 8 8 18 3 4 5 7 25
2022/2023176 22 19 9 27 14 20 9 9 28 2 15 2
2023/2024204 15 21 17 12 23 25 25 8 6 13 21 18
2024/2025404 1 60 28 31 68 34 27 66 54 35 0 0
Totale 900